This 45-minute webinar hosted by The Journal of Precision Medicine and the Precision Medicine Leaders' Summits brings together two experts in the field of precision oncology – Clynt Taylor, CEO of Trapelo Health and Lori Brisbin, Vice President of Precision Medicine at Texas Oncology.
Together, they discuss the challenges and solutions for managing precision oncology in this complex and rapidly evolving ecosystem of healthcare.
During this webinar you'll learn:
Why now is the time to implement collaborative solutions that address the complexities of precision medicine for greater patient access
How can cancer centers and oncology networks ensure that every doctor has clear easy access to “pathways” for molecular testing so that every patient who is a candidate for precision medicine treatment has access?
How Texas Oncology, one of the nation’s largest networks, is leveraging the Trapelo platform to support their own precision medicine pathways
How Trapelo can ease the burdens of prior authorization for molecular testing
We wrap up with a live Q&A with audience members from cancer centers, health plans, labs, pharma and more. We had so many great questions we couldn't answer them all during the live presentation. Please download the full Q&A here.
For more, tune in to episode #5 of Precision Medicine Podcast to hear Laura Holmes Haddad's personal story with stage 4 inflammatory breast cancer and how that experience inspired her to become an author and champion for precision medicine.